Key result
Recent trials and experimental studies demonstrate that glucose-insulin-potassium provides a strong protective effect on ischemic myocardium and improves bioenergetic status.
Why the study?
Does glucose-insulin-potassium improve ischemic cardiac dysfunction and reduce injury in patients with acute myocardial infarction or undergoing cardiac surgery?
Does glucose-insulin-potassium improve ischemic cardiac dysfunction and reduce injury in patients with acute myocardial infarction or undergoing cardiac surgery?
Glucose-insulin-potassium provides metabolic support and protects ischemic myocardium during acute myocardial infarction and cardiac surgery.
No takes yet. Share an insight, caveat, or question.
May inform metabolic strategies in AMI and cardiac surgery; leaves open large outcome trials before practice change.
Carl S. Apstein (2000) conducted a review in Acute myocardial infarction or metabolic support during and after cardiac surgery. Glucose-insulin-potassium vs. Placebo was evaluated. Recent trials and experimental studies demonstrate that glucose-insulin-potassium provides a strong protective effect on ischemic myocardium and improves bioenergetic status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: